Premium
An infant with ETV6‐NTRK3 fusion‐positive congenital infantile fibrosarcoma and delayed response to conventional chemotherapy avoiding the need for TRK inhibition
Author(s) -
Vedi Aditi,
Holland Katherine,
Cross Justin,
Muthusamy Brinda,
Behjati Sam,
Hook C. Elizabeth,
Murray Matthew J.
Publication year - 2020
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.28628
Subject(s) - medicine , chemotherapy , fibrosarcoma , trk receptor , oncology , pediatrics , pathology , receptor , neurotrophin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom